Quantbot Technologies LP Precigen, Inc. Transaction History

Quantbot Technologies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.15 - $2.53 $27,714 - $60,972	-24,100 Reduced 56.44%	18,600 $24,000
Q1 2022 May 16, 2022	BUY	$1.91 - $3.98 $81,557 - $169,946	42,700 New	42,700 $90,000
Q4 2021 Feb 11, 2022	SELL	$3.53 - $5.5 $16,238 - $25,300	-4,600 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$4.99 - $6.55 $13,473 - $17,685	-2,700 Reduced 36.99%	4,600 $22,000
Q2 2021 Aug 12, 2021	SELL	$6.24 - $8.22 $49,657 - $65,414	-7,958 Reduced 52.16%	7,300 $47,000
Q1 2021 May 14, 2021	BUY	$6.74 - $10.95 $98,120 - $159,410	14,558 Added 2079.71%	15,258 $105,000
Q4 2020 Feb 12, 2021	BUY	$3.75 - $10.56 $2,625 - $7,392	700 New	700 $7,000

140

161M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $281M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.